New appointments at PhRMA
This article was originally published in Scrip
The US trade group PhRMAhas appointed Dr Bob Filippone and Tom Moore to the positions of vice-president for federal government affairs. Dr Filippone joined PhRMA in 2004 and has focused on various legislative and policy issues, including intellectual property protection. Mr Moore rejoined PhRMA in May after working as director of international corporate affairs for Amgen. Both men have Democratic political ties.
You may also be interested in...
FDA's recommendation that COVID-19 vaccine sponsors conduct two months of median follow-up to support an emergency use authorization may not be long enough, some experts say in what can be viewed as validation for agency's position in battle with White House.
There are 18 people on the committee that will issue the first recommendations on COVID-19 vaccine development and licensure. Among the experts are a University of Michigan epidemiologist who will serve as acting chairman and seven temporary voting members, two of whom required conflict-of-interest waivers.
Unlike AMAG's Makena, nearly all the products that have seen their accelerated approvals pulled have left the market quietly, our infographic shows.